Last10K.com

Haemonetics Corp (HAE) SEC Filing 10-Q Quarterly Report for the period ending Saturday, January 1, 2022

SEC Filings

Haemonetics Corp

CIK: 313143 Ticker: HAE
DOCUMENT AND ENTITY INFORMATION - shares
9 Months Ended
Jan. 01, 2022
Feb. 04, 2022
Cover [Abstract]  
Document Type10-Q 
Document Quarterly Reporttrue 
Document Period End DateJan. 01, 2022 
Document Transition Reportfalse 
Entity File Number001-14041 
Entity Registrant NameHAEMONETICS CORP 
Entity Central Index Key0000313143 
Current Fiscal Year End Date--04-02 
Document Fiscal Year Focus2022 
Document Fiscal Period FocusQ3 
Amendment Flagfalse 
Entity Incorporation, State or Country CodeMA 
Entity Tax Identification Number04-2882273 
Entity Address, Address Line One125 Summer Street 
Entity Address, City or TownBoston, 
Entity Address, State or ProvinceMA 
Entity Address, Postal Zip Code02110 
City Area Code781 
Local Phone Number848-7100 
Title of 12(b) SecurityCommon stock, $.01 par value per share 
Trading SymbolHAE 
Security Exchange NameNYSE 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryLarge Accelerated Filer 
Entity Small Businessfalse 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 51,111,595

View differences made from one quarter to another to evaluate Haemonetics Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Haemonetics Corp.

Continue

Assess how Haemonetics Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Haemonetics Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Rating

Learn More
Bullish Bearish Neutral
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Financial
M & A
Revenue
Other
Filter by Subcategory:
All
Expense
Income
Geography
Earnings
Product
Cash Flow
Other
Inside Haemonetics Corp's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parentheticals)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Income And Comprehensive Income
Condensed Consolidated Statements Of Stockholders' Equity
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss (Details)
Accumulated Other Comprehensive Loss (Tables)
Acquisition
Acquisition (Details)
Acquisition (Tables)
Basis Of Presentation
Commitments And Contingencies
Divestiture
Divestiture (Details)
Earnings Per Share
Earnings Per Share (Schedule Of Earnings Per Share Reconciliation) (Details)
Earnings Per Share (Tables)
Financial Instruments And Fair Value Measurements - Allowance For Credit Losses (Details)
Financial Instruments And Fair Value Measures
Financial Instruments And Fair Value Measures (Narrative) (Details)
Financial Instruments And Fair Value Measures (Schedule Of Effect Of Derivative Instruments Designated As Cash Flow Hedges And Those Not Designated As Hedging Instruments) (Details)
Financial Instruments And Fair Value Measures (Schedules Of Derivatives) (Details)
Financial Instruments And Fair Value Measures (Tables)
Income Taxes
Income Taxes (Details)
Inventories
Inventories (Schedule Of Inventories) (Details)
Inventories (Tables)
Leases
Leases (Details)
Notes??Payable And Long-Term Debt
Notes??Payable And Long-Term Debt (Details)
Recent Accounting Pronouncements
Recent Accounting Pronouncements (Narrative) (Details)
Restructuring
Restructuring (Narrative) (Details)
Restructuring (Schedule Of Restructuring And Related Costs) (Details)
Restructuring (Schedule Of Restructuring Reserve By Type Of Cost) (Details)
Restructuring (Tables)
Revenue
Revenue (Details)
Segment And Enterprise-Wide Information
Segment And Enterprise-Wide Information (Details)
Segment And Enterprise-Wide Information (Tables)
Ticker: HAE
CIK: 313143
Form Type: 10-Q Quarterly Report
Accession Number: 0000313143-22-000008
Submitted to the SEC: Tue Feb 08 2022 6:32:45 AM EST
Accepted by the SEC: Tue Feb 08 2022
Period: Saturday, January 1, 2022
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/hae/0000313143-22-000008.htm